Suchergebnisse - "Suthe, Sreedhar Reddy"

PubPharm (18)

1

Engineering CD276/B7-H3-targeted antibody-drug conjugates with enhanced cancer-eradicating capability

enthalten in: Cell reports | 2023

von Feng, Y. | Lee, J. | Yang, L. | +26

2

RON Receptor Tyrosine Kinase in Tumorigenic Stemness as a Therapeutic Target of Antibody-drug Conjugates for Eradication of Triple-negative Breast Cancer Stem Cells

enthalten in: Current cancer drug targets | 2023

von Suthe, S. | Yao, H. | Weng, T. | +1

3

Antibody-drug Conjugate PCMC1D3-Duocarmycin SA as a Novel Therapeutic Entity for Targeted Treatment of Cancers Aberrantly Expressing MET Receptor Tyrosine Kinase

enthalten in: Current cancer drug targets | 2022

von Hudson, R. | Yao, H. | Suthe, S. | +2

4

Antibody-drug Conjugate PCMC1D3-Duocarmycin SA as a Novel Therapeutic Entity for Targeted Treatment of Cancers Aberrantly Expressing MET Receptor Tyrosine Kinase

enthalten in: Current cancer drug targets | 2022

von Hudson, R. | Yao, H. | Suthe, S. | +2

5

Antibody-drug conjugates targeting RON receptor tyrosine kinase as a novel strategy for treatment of triple-negative breast cancer

enthalten in: Drug discovery today | 2020

von Yao, H. | Suthe, S. | Hudson, R. | +1

6

Targeting RON receptor tyrosine kinase for treatment of advanced solid cancers : antibody-drug conjugates as lead drug candidates for clinical trials

enthalten in: Therapeutic advances in medical oncology | 2020

von Yao, H. | Suthe, S. | Tong, X. | +1

7

Therapeutic efficacy of a novel humanized antibody-drug conjugate recognizing plexin-semaphorin-integrin domain in the RON receptor for targeted cancer therapy

enthalten in: Journal for immunotherapy of cancer | 2019

von Tong, X. | Feng, L. | Suthe, S. | +6

8

Therapeutic efficacy of a novel humanized antibody-drug conjugate recognizing plexin-semaphorin-integrin domain in the RON receptor for targeted cancer therapy

enthalten in: Journal for ImmunoTherapy of Cancer | 2019

von Tong, X. | Feng, L. | Suthe, S. | +6

9

Therapeutic efficacy of a novel humanized antibody-drug conjugate recognizing plexin-semaphorin-integrin domain in the RON receptor for targeted cancer therapy

enthalten in: Journal for ImmunoTherapy of Cancer | 2019

von Tong, X. | Feng, L. | Suthe, S. | +6

10

Correction to : Therapeutic efficacy, pharmacokinetic profiles, and toxicological activities of humanized antibody-drug conjugate Zt/g4-MMAE targeting RON receptor tyrosine kinase for cancer therapy

enthalten in: Journal for immunotherapy of cancer | 2019

von Yao, H. | Feng, L. | Suthe, S. | +9

ErratumFor: J Immunother Cancer. 2019 Mar 14;7(1):75. - PMID 30871619